Authors
Latest:
Attitudes, Barriers, and Perceptions Influence Naloxone Prescribing by PharmacistsEvidence suggests that they are not actively using their prescriptive authority, but a new study aims to identify factors affecting their related behaviors.
Latest:
Tackling Vaccination Hesitancy Unrelated to Medical ExemptionIronically, it is often during times when vaccine-preventable disease rates are lowest that public opposition to them is most pervasive, and this certainly seems to be the case with contemporary antivaccination movements in the United States.
Latest:
Persistence With Mirabegron Versus Tolterodine in Patients With Overactive BladderIn a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Latest:
The Appropriateness of Use of 3 Classes of Psychotropic Medications in Children and AdolescentsFor the majority of children and adolescents receiving a psychotropic medication there is a valid medical diagnosis.
Latest:
Drug for Relapsing Forms of Multiple Sclerosis Pulled from MarketBiogen and AbbVie recently announced a voluntary, worldwide withdrawal of daclizumab (Zinbryta®).
Latest:
Fostering Rapid Innovation During a Time of CrisisPromoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
Latest:
The Career Game Changers of PharmacyWhich game will your pharmacy career resemble: Risk, Cranium, Chutes and Ladders, or Candy Land?
Latest:
Drug-Induced Liver Injury in Children: Atomoxetine and Nonstimulants for ADHDMechanisms of drug-induced liver injury in children, case reports of atomoxetine-induced liver injury in children, and nonstimulant options for attention-deficit/hyperactivity disorder.
Latest:
Prescriptions for Man, and Man's Best FriendVeterinary pharmacy is a difficult field. Pharmacists must judge if the prescribed dose is appropriate for the pet, based upon age, gender, species, and indication.
Latest:
Breast Cancer: the Clinician's InvolvementFor many women, the fear of breast cancer is always present.
Latest:
2010 Technology Innovator of the Year: Tim Davis2010 Technology Innovator of the Year Tim Davis is plugged in, and uses technology every day to help patients and run his business more efficiently.
Latest:
Managed Care Biologics and InjectablesPayer response to new entrants to the multiple sclerosis (MS) market is mixed as some believe that there remain meaningful, major unmet needs in the MS category, according to The Zitter Group's Spring 2011 Managed Care Biologics and Injectables Index.
Latest:
Private-payer Costs for Employees with Treatment-resistant DepressionIndividuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Latest:
Dolutegravir Is Susceptible to Chelation-Type InteractionsCommon medications containing polyvalent cations should be separated to prevent decreased absorption of the HIV therapy.
Latest:
Patients With Pain Benefit From a Multimodal ApproachThis method may optimize pain control and could be an answer to the opioid crisis.
Latest:
Biosimilars Action Plan: There's No Better Time Than NowSeveral hurdles remain for biosimilars to flourish in the US market.
Latest:
HIV-Positive Patients with Comorbidities Benefit from Personalized, Pharmacist-Led CareHIV-specialized pharmacies meet the complex needs of HIV-positive patients, helping to provide comprehensive patient care and improve medication adherence to both anti-retroviral therapies and non-HIV medications.
Latest:
After Doughnut Hole Closure, Oral Anticancer Drug Costs Still Too High for ManyStudy finds that patients prescribed expensive drugs will continue to face high out-of-pocket costs.
Latest:
Focus on Hepatitis C: Bridging the Gap from New Drug Therapy to Successful TreatmentSpecialty pharmacists can help patients achieve successful outcomes in the treatment of hepatitis C by providing comprehensive clinical consultations on triple therapies.
Latest:
Connecting the Dots for a Digital Deploy: A Guide to Engaging Pharma StakeholdersStrategic tips for pharma to develop an overall business strategy around digital engagement.
Latest:
The Hidden Adherence Problem: HPV Vaccination Series Completion Is Not as Easy as 1, 2, 3Pharmacists can help improve vaccination completion rates.
Latest:
Identifying and Managing Fungal Skin InfectionsMoist, warm skin provides the ideal environment for dermatophytes—fungi that cause skin infections—to flourish.
Latest:
Statin-Fenofibrate Combination Therapy in an ACCORD Population: A Retrospective AnalysisRetrospective analysis of a population meeting criteria for the ACCORD lipid trial supported adjunct fenofibrate in patients with reduced low-density lipoprotein cholesterol and elevated triglycerides.
